| Discharge Regimen | Year of Transplant | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | ||
| Total | Patients | 6,486 | 6,403 | 6,712 | 6,973 | 7,129 | 7,600 | 8,077 | 8,690 | 8,759 | 8,809 |
| Steroids Avoided | 166 | 256 | 341 | 513 | 979 | 1,521 | 2,106 | 2,724 | 2,824 | 2,853 | |
| Rate | 2.6% | 4.0% | 5.1% | 7.4% | 13.7% | 20.0% | 26.1% | 31.3% | 32.2% | 32.4% | |
| CyA | Patients | 351 | 214 | 104 | 91 | 105 | 114 | 51 | 39 | 35 | 14 |
| Steroids Avoided | 16 | 4 | 2 | 2 | 11 | 12 | 10 | 11 | 8 | 2 | |
| Rate | 4.6% | 1.9% | 1.9% | 2.2% | 10.5% | 10.5% | 19.6% | 28.2% | 22.9% | 14.3% | |
| Tac | Patients | 197 | 234 | 341 | 394 | 221 | 277 | 358 | 288 | 268 | 268 |
| Steroids Avoided | 11 | 34 | 78 | 154 | 65 | 90 | 133 | 156 | 97 | 115 | |
| Rate | 5.6% | 14.5% | 22.9% | 39.1% | 29.4% | 32.5% | 37.2% | 54.2% | 36.2% | 42.9% | |
| CyA+MMF | Patients | 3,164 | 2,522 | 1,970 | 1,773 | 1,517 | 1,281 | 903 | 787 | 636 | 427 |
| Steroids Avoided | 31 | 45 | 44 | 43 | 97 | 117 | 77 | 170 | 158 | 59 | |
| Rate | 1.0% | 1.8% | 2.2% | 2.4% | 6.4% | 9.1% | 8.5% | 21.6% | 24.8% | 13.8% | |
| Tac+MMF | Patients | 1,642 | 1,994 | 2,624 | 3,335 | 3,744 | 4,608 | 5,662 | 6,465 | 7,050 | 7,364 |
| Steroids Avoided | 35 | 53 | 75 | 125 | 400 | 909 | 1,558 | 2,087 | 2,331 | 2,469 | |
| Rate | 2.1% | 2.7% | 2.9% | 3.7% | 10.7% | 19.7% | 27.5% | 32.3% | 33.1% | 33.5% | |
| CyA+Aza | Patients | 366 | 233 | 123 | 56 | 32 | 14 | 9 | 7 | 10 | 7 |
| Steroids Avoided | 0 | 1 | 1 | 1 | 2 | 0 | 1 | 0 | 1 | 1 | |
| Rate | 0.0% | 0.4% | 0.8% | 1.8% | 6.3% | 0.0% | 11.1% | 0.0% | 10.0% | 14.3% | |
| Tac+Aza | Patients | 79 | 54 | 84 | 60 | 48 | 26 | 24 | 26 | 17 | 24 |
| Steroids Avoided | 1 | 1 | 1 | 1 | 1 | 1 | 11 | 9 | 7 | 4 | |
| Rate | 1.3% | 1.9% | 1.2% | 1.7% | 2.1% | 3.8% | 45.8% | 34.6% | 41.2% | 16.7% | |
| CyA+Siro | Patients | 120 | 303 | 294 | 186 | 221 | 211 | 164 | 124 | 124 | 138 |
| Steroids Avoided | 4 | 2 | 11 | 9 | 55 | 93 | 72 | 41 | 60 | 53 | |
| Rate | 3.3% | 0.7% | 3.7% | 4.8% | 24.9% | 44.1% | 43.9% | 33.1% | 48.4% | 38.4% | |
| Tac+Siro | Patients | 11 | 302 | 452 | 339 | 440 | 331 | 214 | 253 | 113 | 59 |
| Steroids Avoided | 0 | 30 | 55 | 73 | 117 | 111 | 76 | 63 | 45 | 17 | |
| Rate | 0.0% | 9.9% | 12.2% | 21.5% | 26.6% | 33.5% | 35.5% | 24.9% | 39.8% | 28.8% | |
| Siro+MMF | Patients | 9 | 85 | 257 | 272 | 211 | 207 | 171 | 156 | 80 | 67 |
| Steroids Avoided | 0 | 5 | 15 | 19 | 35 | 51 | 38 | 60 | 16 | 18 | |
| Rate | 0.0% | 5.9% | 5.8% | 7.0% | 16.6% | 24.6% | 22.2% | 38.5% | 20.0% | 26.9% | |
| Other Regimen | Patients | 547 | 462 | 463 | 467 | 590 | 531 | 521 | 545 | 426 | 441 |
| Steroids Avoided | 68 | 81 | 59 | 86 | 196 | 137 | 130 | 127 | 101 | 115 | |
| Rate | 12.4% | 17.5% | 12.7% | 18.4% | 33.2% | 25.8% | 25.0% | 23.3% | 23.7% | 26.1% | |